Click to copy
Click to copy
Related topics

TG Therapeutics: 2Q Earnings Snapshot

August 9, 2019

NEW YORK (AP) _ TG Therapeutics Inc. (TGTX) on Friday reported a loss of $36.2 million in its second quarter.

The New York-based company said it had a loss of 42 cents per share.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 43 cents per share.

The biopharmaceutical company posted revenue of $38,000 in the period.

TG Therapeutics shares have risen 68% since the beginning of the year. The stock has decreased 40% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TGTX at https://www.zacks.com/ap/TGTX

All contents © copyright 2019 The Associated Press. All rights reserved.